Replies to post #3468 on Galectin Therapeutics Inc. (GALT)

[Coolec78]

But still it is 17%more than keytruba alone plus 2 patients stabilized makes over 60. Not bad for hard to treat patients.
Plus this is only 1b trial about safety. There is some room to play with dosage and length of the therapy.

[Coolec78]

Take A look 33% keytruba alone, 50% with GALT. That's almost 50% better response rate.